Arcturus Therapeutics Holdings (ARCT) Non-Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings' Non-Current Assets history runs 9 years deep, the most recent figure standing at $28.5 million for Q1 2026.

• Quarterly Non-Current Assets fell 46.16% year-over-year to $28.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.1 million (down 26.88% YoY) and the FY2025 annual result came in at $29.7 million, down 22.02% from the prior year.
• Non-Current Assets was $28.5 million for Q1 2026 at Arcturus Therapeutics Holdings, down from $29.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $64.4 million in Q3 2023 and bottomed at $15.0 million in Q1 2022.
• A 5-year average of $40.9 million and a median of $42.8 million in 2023 frame the typical range for Non-Current Assets.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 322.36% — and 2026, when it tumbled 46.16%.
• Arcturus Therapeutics Holdings' Non-Current Assets stood at $47.1 million in 2022, then dropped by 9.02% to $42.8 million in 2023, then slipped by 11.03% to $38.1 million in 2024, then fell by 22.02% to $29.7 million in 2025, then retreated by 3.95% to $28.5 million in 2026.
• Business Quant data shows ARCT's Non-Current Assets at $28.5 million in Q1 2026, $29.7 million in Q4 2025, and $33.1 million in Q3 2025.